Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls

NCT07776275 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-04-21
Last updated
2026-08-21

Condition(s) studied

Cervicogenic HeadacheChronic Neck Pain

Study summary

The goal of this observational study is to compare physical findings across three adult groups. Cervicogenic headache (CGH) is a headache linked to a problem in the neck. Neck pain may affect posture, muscle function, grip strength, and sensitivity to pressure. Researchers do not know whether CGH has a distinct pattern of these findings.

The main questions are:

* Do posture, grip strength, muscle stiffness, elasticity, and pressure sensitivity differ among the groups?
* Are any differences more closely associated with CGH than with neck pain?

Researchers will compare adults ages 25 through 60. One group will include people with CGH lasting at least three months. Another group will include people with neck pain lasting at least six months. People in the neck pain group will have no headaches. Healthy participants will have no neck pain or headaches.

Researchers will not provide treatment or change participants' usual care. Each participant will complete one study visit lasting about 15 minutes. Participants will:

* Answer short questions about their health and pain
* Stand while researchers measure their head and neck posture
* Squeeze a device that measures grip strength
* Complete brief tests of neck muscle stiffness and elasticity
* Tell researchers when applied pressure first becomes painful

Researchers will compare results across the three groups. The findings may guide future CGH assessment and treatment research.

Eligibility

Sex
ALL
Min age
25 Years
Max age
60 Years
Healthy volunteers
Accepted
* Inclusion Criteria: * Aged 25 to 60 years * Able to provide written informed consent * Meeting the criteria for one of the following groups: * Cervicogenic headache: physician diagnosis according to the International Classification of Headache Disorders, 3rd edition, with symptoms lasting at least 3 months * Chronic nonspecific neck pain: neck pain lasting at least 6 months without headache * Healthy control: no neck pain or headache Exclusion Criteria: * Receipt of physiotherapy for headache or neck pain during the previous 6 months * Diagnosis of a headache disorder other than cervicogenic headache, including migraine or tension-type headache, or a diagnosis of trigeminal neuralgia * History of cervical spine surgery or significant cervical trauma * Current or previous diagnosis of a tumor or cancer * Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological, or psychiatric disorder * Rheumatoid arthritis * Congenital cervical abnormality * Cervical spondylolisthesis or cervical instability * Active infection * Temporomandibular joint dysfunction * Dizziness or visual disturbance accompanying headache * Any clinical red flag suggesting serious cervical pathology * Pregnancy or breastfeeding * Upper-extremity injury, surgery, or another condition affecting handgrip strength * Serious musculoskeletal disorder affecting cervical posture or muscle measurements * Inability to complete the questionnaire-based or instrument-based assessments

Primary outcome measure(s)

  • Bilateral Upper Trapezius Muscle Stiffness — During the single assessment session at enrollment
    Upper trapezius muscle stiffness will be assessed bilaterally using the MyotonPRO device. Three consecutive measurements will be obtained at the midpoint between the C7 spinous process and the lateral border of the acromion. The mean of the three measurements will be used. Stiffness will be expressed in newtons per meter (N/m), with higher values indicating greater stiffness.
  • Bilateral Upper Trapezius Logarithmic Decrement — During the single assessment session at enrollment
    Upper trapezius logarithmic decrement will be assessed bilaterally using the MyotonPRO device at the same standardized measurement site. Three consecutive measurements will be obtained on each side, and their mean will be used. Logarithmic decrement is a dimensionless inverse indicator of tissue elasticity, with lower values indicating greater elasticity.

Trial sites (1)

FacilityCityRegionStatus
Medipol Sefaköy Üniversite Hastanesi Istanbul Sefaköy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07776275 on ClinicalTrials.gov ↗ ← All trials in Turkey